Full Text (PDF)
Case Report

Sebaceous Carcinoma of Eyelid: A Report of Two Cases with Review of Literature

Punam Pd. Bhadani , Punam Prasad Bhadani* , Umesh Kumar Bhadani**

Author Information

Licence:




Indian Journal of Pathology: Research and Practice 6(2 (Part-2)):p 487-490, APRIL - JUNE 2017. | DOI: http://dx.doi.org/10.21088/ijprp.2278.148X.62(pt-II)17.26

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Background: Sebaceous carcinoma of the eyelid is rare. The diagnosis might be difficult because of its ability to masquerade as other periocular lesions. Prognosis is still regarded as being poor compared with most other malignant eyelid tumors with a mortality second only to malignant melanoma. The present reported cases analyses clinical and histopathological findings. Case Reports: Two case reports were presented here. One presented as primary complaint of progressive painless mass in left lower eyelid in a 75 year female and another case in young 30 year old with history of recurrence, operated previously for the same complaint with unavailable previous report. Both cases on histopathology reported as sebaceous gland carcinoma. Conclusion : Early diagnosis and consequent surgical therapy of sebaceous carcinoma of the eyelid leads to a better outcome and higher survival rates than generally assumed. Even local recurrences can be treated successfully. However, sebaceous carcinoma remains a threatening disease, which leads to death in 9% and to mutilating exenteration in 23% published in an English literature.

Keywords: Sebaceous carcinoma; Meibomian gland; Eyelid.


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI: http://dx.doi.org/10.21088/ijprp.2278.148X.62(pt-II)17.26

Keywords


Article Level Metrics

Last Updated

Sunday 12 July 2026, 14:00:10 (IST)


2018

Accesses

4
434
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share